| Long name: |
ADK Primary Polyclonal Antibody |
| Also known as: |
ADK PAb |
| Category: |
Primary Antibodies |
| Conjugation: |
Unconjugated |
| Target Antigen: |
ADK |
| Specificity: |
This is a highly specific antibody against ADK |
| Modification(s): |
None |
| Modification site(s): |
Unmodified antibody |
| Clonality: |
Polyclonal antibody |
| Clone number: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Subcellular location: |
Extracellular |
| Source: |
This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human ADK/adenylate kinase |
| Gene ID number: |
132 |
| Tested Applications: |
IF(IHC-P), IHC-P, WB |
| Recommended dilutions: |
IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity: |
Mouse, Rat, Human |
| Cross reactive species details: |
not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen: |
2 regions were identified with significant sequence identity to microbial ribokinase and fructokinases and a bacterial inosine/guanosine kinase, ADK is a structurally distinct mammalian nucleoside kinase that appears to be akin to sugar kinases of microbial origin, Animal studies have demonstrated that a deficiency of adenosine metabolism a powerful contributor to the development of neonatal hepatic steatosis, In contrast, The encoded protein does not present any sequence similarities to other well characterized mammalian nucleoside kinases, Thus, and immune systems and inhibitors of ADK could play an important pharmacological role in increasing intravascular adenosine concentrations and acting as antiinflammatory agents, nervous, providing a model for the rapid development of postnatally lethal fatty liver, respiratory, widespread effects on the cardiovascular |
| Purification method: |
This antibody was purified via Protein A |
| Storage conditions: |
50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names: |
2310026J05Rik, 5033405D03Rik, ADK_HUMAN, AI255373, AI987814, AK, AK, Adenosine 5'-phosphotransferase, Adenosine kinase, Full=Adenosine 5'-phosphotransferase, MGC6593, OTTHUMP00000019864, OTTHUMP00000019865, Adenosine kinase |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target: |
ADK |
| Short name: |
ADK Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
adenosine kinase (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
ADK and IDBG-79046 and ENSG00000156110 and 132, AK, Adk and IDBG-137102 and ENSMUSG00000039197 and 11534, alcohol group as acceptor, alcohol group as acceptor and also this GO :0044822 : poly(A) RNA binding and also this GO :0046872 : metal ion binding, alcohol group as acceptor and molecular function this GO :0032922 and circadian regulation of gene expression and biological process this GO :0042102 and positive regulation of T cell proliferation and biological process this GO :0043101 and purine-containing compound salvage and biological process this GO :0044209 and AMP salvage and biological process this GO :0044281 and small molecule metabolic process and biological process this GO :0044342 and type B pancreatic cell proliferation and biological process this GO :0044822 and poly(A) RNA binding and molecular function this GO :0046085 and adenosine metabolic process and biological process this GO :0046872 and metal ion binding and molecular function this GO :0055086 and nucleobase-containing small molecule metabolic process and biological process, nuclei, phosphotransferase activity, this GO :0004001 and adenosine kinase activity and molecular function this GO :0005524 and ATP binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0005829 and cytosol and cellular component this GO :0006144 and purine nucleobase metabolic process and biological process this GO :0006166 and purine ribonucleoside salvage and biological process this GO :0006175 and dATP biosynthetic process and biological process this GO :0009156 and ribonucleoside monophosphate biosynthetic process and biological process this GO :0010613 and positive regulation of cardiac muscle hypertrophy and biological process this GO :0016310 and phosphorylation and biological process this GO :0016773 and phosphotransferase activity, this GO :0004001 : adenosine kinase activity, this GO :0004001 : adenosine kinase activity and also this GO :0005524 : ATP binding and also this GO :0016773 : phosphotransferase activity, this GO :0005524 : ATP binding, this GO :0016773 : phosphotransferase activity, this GO :0044822 : poly(A) RNA binding, this GO :0046872 : metal ion binding, adenosine kinase |
| Identity: |
257 |
| Gene: |
ADK |
More about : ADK |
| Long gene name: |
adenosine kinase |
| Synonyms: |
AK |
| Synonyms name: |
adenosine 5', -phosphotransferase |
| Locus: |
10q22, 2 |
| Discovery year: |
1986-01-01 |
| GenBank acession: |
U50196 |
| Entrez gene record: |
132 |
| Pubmed identfication: |
8577746 |
| RefSeq identity: |
NM_006721 |
| Havana BLAST/BLAT: |
OTTHUMG00000018506 |